CURRENT OPINION IN LIPIDOLOGY

CURRENT OPINION IN LIPIDOLOGY

CURR OPIN LIPIDOL
影响因子:4.6
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:ENGLAND
出版社:Lippincott Williams and Wilkins Ltd.
发刊时间:0
发刊频率:Bimonthly
收录数据库:SCIE/Scopus收录
ISSN:0957-9672

期刊介绍

With its easy-to-digest reviews on important advances in world literature, Current Opinion in Lipidology offers expert evaluation on a wide range of topics from six key disciplines including nutrition and metabolism, genetics and molecular biology, and hyperlipidaemia and cardiovascular disease. Published bimonthly, each issue covers in detail the most pertinent advances in these fields from the previous year. This is supplemented by a section of Bimonthly Updates, which deliver an insight into new developments at the cutting edge of the disciplines covered in the journal.
《血脂学的最新观点》以易于消化的方式对世界文献中的重要进展进行了综述,并就营养与代谢、遗传学和分子生物学以及高脂血症和心血管疾病等六个关键学科的广泛主题提供了专家评估。每两个月出版一次,每期都详细介绍前一年在这些领域取得的最相关进展。这是补充了一个部分的双月刊更新,提供了一个新的发展,在最前沿的学科所涵盖的杂志洞察。
年发文量 42
国人发稿量 1.13
国人发文占比 0.03%
自引率 -
平均录取率0
平均审稿周期 较慢,6-12周
版面费 -
偏重研究方向 医学-内分泌学与代谢
期刊官网 http://journals.lww.com/co-lipidology/Pages/default.aspx
投稿链接 https://www.editorialmanager.com/COL

期刊高被引文献

Fibroblast growth factors in control of lipid metabolism: from biological function to clinical application
来源期刊:Current Opinion in LipidologyDOI:10.1097/MOL.0000000000000599
New insights into angiopoietin-like proteins in lipid metabolism and cardiovascular disease risk
来源期刊:Current Opinion in LipidologyDOI:10.1097/MOL.0000000000000600
Bempedoic acid: effects on lipoprotein metabolism and atherosclerosis
来源期刊:Current Opinion in LipidologyDOI:10.1097/MOL.0000000000000565
The evolution of genetic-based risk scores for lipids and cardiovascular disease
来源期刊:Current Opinion in LipidologyDOI:10.1097/MOL.0000000000000576
Chylomicron retention disease: genetics, biochemistry, and clinical spectrum
来源期刊:Current Opinion in LipidologyDOI:10.1097/MOL.0000000000000578
Role of serum amyloid A in atherosclerosis.
来源期刊:Current opinion in lipidologyDOI:10.1097/MOL.0000000000000616
Pathways of smooth muscle foam cell formation in atherosclerosis
来源期刊:Current Opinion in LipidologyDOI:10.1097/MOL.0000000000000574
Bile acid alterations in nonalcoholic fatty liver disease, obesity, insulin resistance and type 2 diabetes: what do the human studies tell?
来源期刊:Current Opinion in LipidologyDOI:10.1097/MOL.0000000000000597
Molecular regulation of plasma lipid levels during systemic inflammation and sepsis
来源期刊:Current Opinion in LipidologyDOI:10.1097/MOL.0000000000000577
Intestinal lymphatic vessels and their role in chylomicron absorption and lipid homeostasis.
来源期刊:Current opinion in lipidologyDOI:10.1097/MOL.0000000000000626
Fatty liver, cardiometabolic disease and mortality.
来源期刊:Current opinion in lipidologyDOI:10.1097/MOL.0000000000000652
Regulation of lipid rafts, angiogenesis and inflammation by AIBP
来源期刊:Current Opinion in LipidologyDOI:10.1097/MOL.0000000000000596
Lipoprotein metabolism in liver diseases
来源期刊:Current Opinion in LipidologyDOI:10.1097/MOL.0000000000000569
The biochemical and genetic diagnosis of lipid disorders
来源期刊:Current Opinion in LipidologyDOI:10.1097/MOL.0000000000000590
High-density lipoprotein: our elusive friend.
来源期刊:Current opinion in lipidologyDOI:10.1097/MOL.0000000000000612
Subclinical coronary atherosclerosis and cardiovascular risk stratification in heterozygous familial hypercholesterolemia patients undergoing statin treatment
来源期刊:Current Opinion in LipidologyDOI:10.1097/MOL.0000000000000573
Dietary fat and risk of type 2 diabetes
来源期刊:Current Opinion in LipidologyDOI:10.1097/MOL.0000000000000567
Effects of apolipoprotein E on nutritional metabolism in dementia
来源期刊:Current Opinion in LipidologyDOI:10.1097/MOL.0000000000000566
From HDL-cholesterol to HDL-function: cholesterol efflux capacity determinants
来源期刊:Current Opinion in LipidologyDOI:10.1097/MOL.0000000000000589
The E3 ubiquitin ligase inducible degrader of the LDL receptor/myosin light chain interacting protein in health and disease.
来源期刊:Current opinion in lipidologyDOI:10.1097/MOL.0000000000000593
Cholesterol membrane content has a ubiquitous evolutionary function in immune cell activation: the role of HDL.
来源期刊:Current opinion in lipidologyDOI:10.1097/mol.0000000000000642
Regulation of calcific vascular and valvular disease by nuclear receptors.
来源期刊:Current opinion in lipidologyDOI:10.1097/MOL.0000000000000632
Recent developments in lipodystrophy.
来源期刊:Current opinion in lipidologyDOI:10.1097/MOL.0000000000000613
Senescent cells in the development of cardiometabolic disease
来源期刊:Current Opinion in LipidologyDOI:10.1097/MOL.0000000000000602
Triglycerides and endothelial function: molecular biology to clinical perspective.
来源期刊:Current opinion in lipidologyDOI:10.1097/MOL.0000000000000630
Update on low-density lipoprotein cholesterol quantification.
来源期刊:Current opinion in lipidologyDOI:10.1097/MOL.0000000000000611
Lipid management in people with peripheral artery disease.
来源期刊:Current opinion in lipidologyDOI:10.1097/mol.0000000000000638
Current status of familial hypercholesterolemia in Chinese populations
来源期刊:Current Opinion in LipidologyDOI:10.1097/MOL.0000000000000580
Implications of serial coronary computed tomography angiography in the evaluation of coronary plaque progression.
来源期刊:Current opinion in lipidologyDOI:10.1097/MOL.0000000000000645
Can atherosclerosis be cured?
来源期刊:Current opinion in lipidologyDOI:10.1097/MOL.0000000000000644
Dietary fructose and dyslipidemia: new mechanisms involving apolipoprotein CIII.
来源期刊:Current opinion in lipidologyDOI:10.1097/MOL.0000000000000653
Nonesterified fatty acids, cognitive decline, and dementia.
来源期刊:Current opinion in lipidologyDOI:10.1097/MOL.0000000000000656
Apolipoprotein M: new connections with diet, adipose tissue and metabolic syndrome.
来源期刊:Current opinion in lipidologyDOI:10.1097/MOL.0000000000000654
Integrative roles of microRNAs in lipid metabolism and dyslipidemia
来源期刊:Current Opinion in LipidologyDOI:10.1097/MOL.0000000000000603
SPPARM alpha: the Lazarus effect.
来源期刊:Current opinion in lipidologyDOI:10.1097/mol.0000000000000640
Strategies to alter the trajectory of atherosclerotic cardiovascular disease.
来源期刊:Current opinion in lipidologyDOI:10.1097/MOL.0000000000000643
Cannabis effects on lipoproteins
来源期刊:Current Opinion in LipidologyDOI:10.1097/MOL.0000000000000575
Squalene: friend or foe for cancers.
来源期刊:Current opinion in lipidologyDOI:10.1097/MOL.0000000000000619
The future of apolipoprotein E mimetic peptides in the prevention of cardiovascular disease.
来源期刊:Current opinion in lipidologyDOI:10.1097/MOL.0000000000000615
Non-HDL cholesterol should not generally replace LDL cholesterol in the management of hyperlipidaemia.
来源期刊:Current opinion in lipidologyDOI:10.1097/MOL.0000000000000614
Is hypertriglyceridemia atherogenic?
来源期刊:Current opinion in lipidologyDOI:10.1097/MOL.0000000000000622
Inheritance of high and low HDL: mechanisms and management.
来源期刊:Current opinion in lipidologyDOI:10.1097/MOL.0000000000000610
Proprotein convertase subtilisin/kexin type 9 inhibitors and lipoprotein(a)-mediated risk of atherosclerotic cardiovascular disease: more than meets the eye?
来源期刊:Current opinion in lipidologyDOI:10.1097/mol.0000000000000641
Neointimal hyperplasia: are fatty acid transport proteins a new therapeutic target?
来源期刊:Current opinion in lipidologyDOI:10.1097/MOL.0000000000000627
The role of the small intestine in modulating metabolism and inflammation in atherosclerosis and cancer.
来源期刊:Current opinion in lipidologyDOI:10.1097/MOL.0000000000000629
Metabolomic and gene expression analysis to study the effects of dietary saturated and polyunsaturated fats.
来源期刊:Current opinion in lipidologyDOI:10.1097/MOL.0000000000000651
Monogenic, polygenic, and oligogenic familial hypercholesterolemia
来源期刊:Current Opinion in LipidologyDOI:10.1097/mol.0000000000000609
Maximizing the benefits of cholesterol-lowering drugs.
来源期刊:Current opinion in lipidologyDOI:10.1097/MOL.0000000000000631
Genetics-driven discovery of novel regulators of lipid metabolism
来源期刊:Current Opinion in LipidologyDOI:10.1097/MOL.0000000000000605

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
0.00%18.7%--

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q2区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
BIOCHEMISTRY & MOLECULAR BIOLOGY
Q2

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2025年3月最新升级版
医学3区
BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学
3区
ENDOCRINOLOGY & METABOLISM 内分泌学与代谢
3区
PERIPHERAL VASCULAR DISEASE 外周血管病
3区
2023年12月升级版
医学3区
BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学
3区
ENDOCRINOLOGY & METABOLISM 内分泌学与代谢
3区
PERIPHERAL VASCULAR DISEASE 外周血管病
3区
2022年12月旧的升级版
医学2区
BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学
3区
ENDOCRINOLOGY & METABOLISM 内分泌学与代谢
3区
PERIPHERAL VASCULAR DISEASE 外周血管病
3区